Torraco, A;
Nasca, A;
Verrigni, D;
Pennisi, A;
Zaki, MS;
Olivieri, G;
Assouline, Z;
Martinelli, D;
Maroofian, R;
Rizza, T;
et al.
Torraco, A; Nasca, A; Verrigni, D; Pennisi, A; Zaki, MS; Olivieri, G; Assouline, Z; Martinelli, D; Maroofian, R; Rizza, T; Di Nottia, M; Invernizzi, F; Lamantea, E; Longo, D; Houlden, H; Prokisch, H; Rötig, A; Dionisi-Vici, C; Bertini, E; Ghezzi, D; Carrozzo, R; Diodato, D
(2021)
Novel NDUFA12 variants are associated with isolated complex I defect and variable clinical manifestation.
Hum Mutat, 42 (6).
pp. 699-710.
ISSN 1098-1004
https://doi.org/10.1002/humu.24195
SGUL Authors: Maroofian, Reza
Preview |
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (658kB)
| Preview
|
Abstract
Isolated biochemical deficiency of mitochondrial complex I is the most frequent signature amongst mitochondrial diseases and is associated with a wide variety of clinical symptoms. Leigh syndrome represents the most frequent neuroradiological finding in patients with complex I defect and >80 monogenic causes have been involved in the disease. In this report, we describe 7 patients from four unrelated families harbouring novel NDUFA12 variants, 6 of them presenting with Leigh syndrome. Molecular genetic characterization was performed using next generation sequencing combined with the Sanger method. Biochemical and protein studies were achieved by enzymatic activities, blue native gel electrophoresis and Western blotting. All patients displayed novel homozygous mutations in the NDUFA12 gene leading to the virtual absence of the corresponding protein. Surprisingly, despite in none of the analyzed patients NDUFA12 protein was detected, they present a different onset and clinical course of the disease. Our report expands the array of genetic alterations in NDUFA12 and underlines phenotype variability associated with NDUFA12 defect. This article is protected by copyright. All rights reserved.
Item Type: |
Article
|
Additional Information: |
This is the peer reviewed version of the following article: Torraco, A., Nasca, A., Verrigni, D., Pennisi, A., Zaki, M. S., Olivieri, G., Assouline, Z., Martinelli, D., Maroofian, R., Rizza, T., Di Nottia, M., Invernizzi, F., Lamantea, E., Longo, D., Houlden, H., Prokisch, H., Rötig, A., Dionisi-Vici, C., Bertini, E., … Diodato, D. (2021). Novel NDUFA12 variants are associated with isolated complex I defect and variable clinical manifestation. Human Mutation, 42, 699– 710, which has been published in final form at https://doi.org/10.1002/humu.24195. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. |
Keywords: |
Leigh syndrome, NADH ubiquinone oxidoreductase, NDUFA12, mitochondrial disease, 0604 Genetics, 1103 Clinical Sciences, Genetics & Heredity |
SGUL Research Institute / Research Centre: |
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) |
Journal or Publication Title: |
Hum Mutat |
ISSN: |
1098-1004 |
Language: |
eng |
Dates: |
Date | Event |
---|
19 May 2021 | Published | 25 March 2021 | Published Online | 6 March 2021 | Accepted |
|
Publisher License: |
Publisher's own licence |
PubMed ID: |
33715266 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/113090 |
Publisher's version: |
https://doi.org/10.1002/humu.24195 |
Statistics
Item downloaded times since 26 Mar 2021.
Actions (login required)
|
Edit Item |